BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Biotech Beach

  Bellicum Announces Updated Clinical Data From BPX-501 Study In Children With Primary Immune Deficiencies And Hemoglobinopathies

  December 5, 2016

   · 

  6 min read
• Drug Development

  Ariad Presents Updated Brigatinib Data With 18.4 Months Median Intracranial Progression Free Survival (PFS) In Alk+ NSCLC Patients With CNS Metastases At The World Conference On Lung Cancer

  December 5, 2016

   · 

  10 min read
• Drug Development

  Mersana Presents Updated Data On Investigational Cancer Antibody Drug Conjugate At World Conference On Lung Cancer

  December 5, 2016

   · 

  4 min read
• Drug Development

  Bristol-Myers Squibb Release: Encouraging Survival Observed With Opdivo (Nivolumab) Plus Yervoy(Ipilimumab) With Longer Follow-Up In First-Line Advanced Non-Small Cell Lung Cancer, In Updated Phase 1b Checkmate -012 Study

  December 5, 2016

   · 

  1 min read
• Drug Development

  Celltrion Healthcare Presents Positive Results For CT-P10, Biosimilar Rituximab Candidate, In Newly Diagnosed Advanced Stage Follicular Lymphoma

  December 5, 2016

   · 

  7 min read
• Drug Development

  Acceleron Pharma And Celgene Announce Preliminary Results From An Investigator Initiated Phase 2 Study Of Sotatercept In Myelofibrosis At The 58th Annual Meeting Of American Society of Hematology

  December 5, 2016

   · 

  8 min read
• Drug Development

  Incyte Release: Pooled Analysis Of Five-Year Data From Two Phase 3 Studies Further Supports Overall Survival Advantage Observed In Patients With Myelofibrosis Treated With Jakafi (Ruxolitinib)

  December 5, 2016

   · 

  8 min read
• Drug Development

  Acceleron Pharma And Celgene Announce Updated Results From Ongoing Phase 2 Studies Of Luspatercept In Myelodysplastic Syndromes At The 58th Annual Meeting Of American Society of Hematology

  December 5, 2016

   · 

  6 min read
• Genetown

  OstriGen Announces New Study Using Ostrich Antibodies In The Treatment Of C. Difficile Infection

  December 5, 2016

   · 

  2 min read
• Drug Development

  Noveome Initiates Phase 2 Clinical Trial Of ST266 For The Treatment Of Allergic Conjunctivitis

  December 5, 2016

   · 

  4 min read